nodes	percent_of_prediction	percent_of_DWPC	metapath
Dyphylline—PDE3A—penis—skin cancer	0.0877	0.214	CbGeAlD
Dyphylline—ADORA1—nerve—skin cancer	0.0392	0.0959	CbGeAlD
Dyphylline—PDE7A—lymphoid tissue—skin cancer	0.0285	0.0698	CbGeAlD
Dyphylline—PDE7A—female reproductive system—skin cancer	0.0275	0.0673	CbGeAlD
Dyphylline—PDE7A—head—skin cancer	0.023	0.0562	CbGeAlD
Dyphylline—PDE7B—head—skin cancer	0.0201	0.0492	CbGeAlD
Dyphylline—PDE4B—nipple—skin cancer	0.0165	0.0403	CbGeAlD
Dyphylline—PDE4C—head—skin cancer	0.0148	0.0362	CbGeAlD
Dyphylline—PDE7B—lymph node—skin cancer	0.0141	0.0344	CbGeAlD
Dyphylline—ADORA2A—lymphoid tissue—skin cancer	0.0134	0.0327	CbGeAlD
Dyphylline—ADORA2A—female reproductive system—skin cancer	0.0129	0.0315	CbGeAlD
Dyphylline—PDE3A—female reproductive system—skin cancer	0.0114	0.028	CbGeAlD
Dyphylline—ADORA1—female reproductive system—skin cancer	0.0111	0.0272	CbGeAlD
Dyphylline—ADORA2A—head—skin cancer	0.0108	0.0264	CbGeAlD
Dyphylline—PDE4B—mammalian vulva—skin cancer	0.00962	0.0235	CbGeAlD
Dyphylline—ADORA1—head—skin cancer	0.00931	0.0228	CbGeAlD
Dyphylline—PDE4D—lymph node—skin cancer	0.00913	0.0223	CbGeAlD
Dyphylline—PDE4B—lymphoid tissue—skin cancer	0.00854	0.0209	CbGeAlD
Dyphylline—PDE4B—female reproductive system—skin cancer	0.00824	0.0201	CbGeAlD
Dyphylline—PDE4A—lymph node—skin cancer	0.00808	0.0198	CbGeAlD
Dyphylline—PDE4B—head—skin cancer	0.00688	0.0168	CbGeAlD
Dyphylline—PDE3A—lymph node—skin cancer	0.00669	0.0164	CbGeAlD
Dyphylline—ADORA1—lymph node—skin cancer	0.00652	0.0159	CbGeAlD
Dyphylline—PDE4B—lymph node—skin cancer	0.00482	0.0118	CbGeAlD
Dyphylline—Abdominal pain upper—Vismodegib—skin cancer	0.00264	0.0805	CcSEcCtD
Dyphylline—ADORA2A—GPCR ligand binding—SMO—skin cancer	0.00152	0.00272	CbGpPWpGaD
Dyphylline—ADORA1—Signaling by GPCR—MC1R—skin cancer	0.00149	0.00268	CbGpPWpGaD
Dyphylline—ADORA2A—GPCR ligand binding—PTGER4—skin cancer	0.00148	0.00265	CbGpPWpGaD
Dyphylline—PDE4B—Signaling by GPCR—MC1R—skin cancer	0.00148	0.00264	CbGpPWpGaD
Dyphylline—ADORA2A—Circadian rythm related genes—CDK4—skin cancer	0.00146	0.00262	CbGpPWpGaD
Dyphylline—Irritability—Imiquimod—skin cancer	0.00145	0.0443	CcSEcCtD
Dyphylline—PDE4B—G Protein Signaling Pathways—HRAS—skin cancer	0.00141	0.00252	CbGpPWpGaD
Dyphylline—PDE4C—GPCR downstream signaling—PTGER4—skin cancer	0.00139	0.0025	CbGpPWpGaD
Dyphylline—PDE4C—Signaling by GPCR—SHH—skin cancer	0.00137	0.00246	CbGpPWpGaD
Dyphylline—PDE4D—Signaling Pathways—PTCH2—skin cancer	0.00137	0.00245	CbGpPWpGaD
Dyphylline—PDE7B—Signaling Pathways—SHH—skin cancer	0.00134	0.0024	CbGpPWpGaD
Dyphylline—PDE7B—Signaling Pathways—RASA1—skin cancer	0.00133	0.00238	CbGpPWpGaD
Dyphylline—PDE4A—Signaling Pathways—PTCH2—skin cancer	0.0013	0.00234	CbGpPWpGaD
Dyphylline—PDE4C—Signaling by GPCR—SMO—skin cancer	0.0013	0.00233	CbGpPWpGaD
Dyphylline—PDE4C—Signaling by GPCR—PTCH1—skin cancer	0.0013	0.00233	CbGpPWpGaD
Dyphylline—ADORA2A—GPCR downstream signaling—MC1R—skin cancer	0.00127	0.00228	CbGpPWpGaD
Dyphylline—PDE3A—Signaling Pathways—PTCH2—skin cancer	0.00127	0.00227	CbGpPWpGaD
Dyphylline—PDE7B—Signaling Pathways—SMO—skin cancer	0.00127	0.00227	CbGpPWpGaD
Dyphylline—PDE7B—Signaling Pathways—PTCH1—skin cancer	0.00127	0.00227	CbGpPWpGaD
Dyphylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—BRAF—skin cancer	0.00127	0.00227	CbGpPWpGaD
Dyphylline—PDE4C—Signaling by GPCR—PTGER4—skin cancer	0.00127	0.00227	CbGpPWpGaD
Dyphylline—PDE7A—Signaling Pathways—SHH—skin cancer	0.00124	0.00223	CbGpPWpGaD
Dyphylline—PDE7A—Signaling Pathways—RASA1—skin cancer	0.00124	0.00221	CbGpPWpGaD
Dyphylline—PDE7B—Signaling Pathways—PTGER4—skin cancer	0.00123	0.00221	CbGpPWpGaD
Dyphylline—ADORA1—Signaling Pathways—PTCH2—skin cancer	0.00122	0.00219	CbGpPWpGaD
Dyphylline—PDE4D—GPCR downstream signaling—PTGER4—skin cancer	0.00121	0.00217	CbGpPWpGaD
Dyphylline—PDE4B—Signaling Pathways—PTCH2—skin cancer	0.00121	0.00216	CbGpPWpGaD
Dyphylline—PDE4D—Signaling by GPCR—SHH—skin cancer	0.00119	0.00214	CbGpPWpGaD
Dyphylline—PDE4C—Signaling Pathways—GLI2—skin cancer	0.00119	0.00214	CbGpPWpGaD
Dyphylline—PDE7A—Signaling Pathways—PTCH1—skin cancer	0.00118	0.00211	CbGpPWpGaD
Dyphylline—PDE7A—Signaling Pathways—SMO—skin cancer	0.00118	0.00211	CbGpPWpGaD
Dyphylline—PDE4A—GPCR downstream signaling—PTGER4—skin cancer	0.00116	0.00207	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling by GPCR—MC1R—skin cancer	0.00115	0.00207	CbGpPWpGaD
Dyphylline—PDE7A—Signaling Pathways—PTGER4—skin cancer	0.00115	0.00206	CbGpPWpGaD
Dyphylline—PDE4C—Signaling Pathways—MC1R—skin cancer	0.00114	0.00204	CbGpPWpGaD
Dyphylline—PDE4A—Signaling by GPCR—SHH—skin cancer	0.00114	0.00204	CbGpPWpGaD
Dyphylline—PDE4D—Signaling by GPCR—SMO—skin cancer	0.00113	0.00203	CbGpPWpGaD
Dyphylline—PDE4D—Signaling by GPCR—PTCH1—skin cancer	0.00113	0.00203	CbGpPWpGaD
Dyphylline—PDE3A—GPCR downstream signaling—PTGER4—skin cancer	0.00112	0.00201	CbGpPWpGaD
Dyphylline—PDE4C—Signaling Pathways—GLI1—skin cancer	0.00112	0.00201	CbGpPWpGaD
Dyphylline—PDE3A—Signaling by GPCR—SHH—skin cancer	0.00111	0.00198	CbGpPWpGaD
Dyphylline—PDE4D—Signaling by GPCR—PTGER4—skin cancer	0.0011	0.00197	CbGpPWpGaD
Dyphylline—PDE7B—Signaling Pathways—FOXO4—skin cancer	0.00109	0.00195	CbGpPWpGaD
Dyphylline—ADORA1—GPCR downstream signaling—PTGER4—skin cancer	0.00108	0.00194	CbGpPWpGaD
Dyphylline—PDE4A—Signaling by GPCR—SMO—skin cancer	0.00108	0.00193	CbGpPWpGaD
Dyphylline—PDE4A—Signaling by GPCR—PTCH1—skin cancer	0.00108	0.00193	CbGpPWpGaD
Dyphylline—PDE4B—GPCR downstream signaling—PTGER4—skin cancer	0.00107	0.00191	CbGpPWpGaD
Dyphylline—ADORA1—Signaling by GPCR—SHH—skin cancer	0.00106	0.00191	CbGpPWpGaD
Dyphylline—PDE4C—Signaling Pathways—SUFU—skin cancer	0.00106	0.0019	CbGpPWpGaD
Dyphylline—PDE4B—Signaling by GPCR—SHH—skin cancer	0.00105	0.00188	CbGpPWpGaD
Dyphylline—PDE4A—Signaling by GPCR—PTGER4—skin cancer	0.00105	0.00188	CbGpPWpGaD
Dyphylline—PDE3A—Signaling by GPCR—SMO—skin cancer	0.00105	0.00188	CbGpPWpGaD
Dyphylline—PDE3A—Signaling by GPCR—PTCH1—skin cancer	0.00105	0.00188	CbGpPWpGaD
Dyphylline—PDE4D—Signaling Pathways—GLI2—skin cancer	0.00104	0.00186	CbGpPWpGaD
Dyphylline—PDE3A—Signaling by GPCR—PTGER4—skin cancer	0.00102	0.00183	CbGpPWpGaD
Dyphylline—PDE4D—Myometrial Relaxation and Contraction Pathways—IL6—skin cancer	0.00102	0.00182	CbGpPWpGaD
Dyphylline—PDE7A—Signaling Pathways—FOXO4—skin cancer	0.00101	0.00182	CbGpPWpGaD
Dyphylline—ADORA1—Signaling by GPCR—PTCH1—skin cancer	0.00101	0.00181	CbGpPWpGaD
Dyphylline—ADORA1—Signaling by GPCR—SMO—skin cancer	0.00101	0.00181	CbGpPWpGaD
Dyphylline—PDE4B—Signaling by GPCR—SMO—skin cancer	0.000997	0.00179	CbGpPWpGaD
Dyphylline—PDE4B—Signaling by GPCR—PTCH1—skin cancer	0.000997	0.00179	CbGpPWpGaD
Dyphylline—PDE4D—Signaling Pathways—MC1R—skin cancer	0.00099	0.00177	CbGpPWpGaD
Dyphylline—PDE4A—Signaling Pathways—GLI2—skin cancer	0.000988	0.00177	CbGpPWpGaD
Dyphylline—ADORA1—Signaling by GPCR—PTGER4—skin cancer	0.000982	0.00176	CbGpPWpGaD
Dyphylline—Flushing—Imiquimod—skin cancer	0.000977	0.0298	CcSEcCtD
Dyphylline—PDE4D—Signaling Pathways—GLI1—skin cancer	0.000976	0.00175	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling by NGF—BRAF—skin cancer	0.000975	0.00175	CbGpPWpGaD
Dyphylline—Diarrhoea—Vismodegib—skin cancer	0.000971	0.0296	CcSEcCtD
Dyphylline—PDE4B—Signaling by GPCR—PTGER4—skin cancer	0.000971	0.00174	CbGpPWpGaD
Dyphylline—PDE3A—Signaling Pathways—GLI2—skin cancer	0.000961	0.00172	CbGpPWpGaD
Dyphylline—PDE4A—Signaling Pathways—MC1R—skin cancer	0.000943	0.00169	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—PTCH2—skin cancer	0.000943	0.00169	CbGpPWpGaD
Dyphylline—PDE4A—Signaling Pathways—GLI1—skin cancer	0.000929	0.00166	CbGpPWpGaD
Dyphylline—ADORA1—Signaling Pathways—GLI2—skin cancer	0.000925	0.00166	CbGpPWpGaD
Dyphylline—PDE4D—Signaling Pathways—SUFU—skin cancer	0.000925	0.00166	CbGpPWpGaD
Dyphylline—PDE3A—Signaling Pathways—MC1R—skin cancer	0.000917	0.00164	CbGpPWpGaD
Dyphylline—PDE4B—Signaling Pathways—GLI2—skin cancer	0.000914	0.00164	CbGpPWpGaD
Dyphylline—PDE3A—Signaling Pathways—GLI1—skin cancer	0.000904	0.00162	CbGpPWpGaD
Dyphylline—Vomiting—Vismodegib—skin cancer	0.000902	0.0275	CcSEcCtD
Dyphylline—PDE4B—Myometrial Relaxation and Contraction Pathways—IL6—skin cancer	0.000896	0.00161	CbGpPWpGaD
Dyphylline—ADORA1—Signaling Pathways—MC1R—skin cancer	0.000883	0.00158	CbGpPWpGaD
Dyphylline—PDE4A—Signaling Pathways—SUFU—skin cancer	0.000881	0.00158	CbGpPWpGaD
Dyphylline—PDE4B—Signaling Pathways—MC1R—skin cancer	0.000872	0.00156	CbGpPWpGaD
Dyphylline—ADORA1—Signaling Pathways—GLI1—skin cancer	0.00087	0.00156	CbGpPWpGaD
Dyphylline—PDE4B—Signaling Pathways—GLI1—skin cancer	0.00086	0.00154	CbGpPWpGaD
Dyphylline—PDE3A—Signaling Pathways—SUFU—skin cancer	0.000857	0.00153	CbGpPWpGaD
Dyphylline—Nausea—Vismodegib—skin cancer	0.000843	0.0257	CcSEcCtD
Dyphylline—Agitation—Imiquimod—skin cancer	0.000842	0.0257	CcSEcCtD
Dyphylline—ADORA2A—GPCR downstream signaling—PTGER4—skin cancer	0.000835	0.0015	CbGpPWpGaD
Dyphylline—ADORA1—Signaling Pathways—SUFU—skin cancer	0.000825	0.00148	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling by GPCR—SHH—skin cancer	0.000822	0.00147	CbGpPWpGaD
Dyphylline—Hypotension—Vemurafenib—skin cancer	0.000819	0.025	CcSEcCtD
Dyphylline—PDE4B—Signaling Pathways—SUFU—skin cancer	0.000815	0.00146	CbGpPWpGaD
Dyphylline—PDE4C—Signaling Pathways—SHH—skin cancer	0.000811	0.00145	CbGpPWpGaD
Dyphylline—Palpitations—Imiquimod—skin cancer	0.00081	0.0247	CcSEcCtD
Dyphylline—PDE4C—Signaling Pathways—RASA1—skin cancer	0.000805	0.00144	CbGpPWpGaD
Dyphylline—ADORA1—Circadian rythm related genes—TP53—skin cancer	0.000805	0.00144	CbGpPWpGaD
Dyphylline—Irritability—Fluorouracil—skin cancer	0.000802	0.0245	CcSEcCtD
Dyphylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—NRAS—skin cancer	0.000797	0.00143	CbGpPWpGaD
Dyphylline—Haematuria—Bleomycin—skin cancer	0.000794	0.0242	CcSEcCtD
Dyphylline—Convulsion—Imiquimod—skin cancer	0.000794	0.0242	CcSEcCtD
Dyphylline—ADORA2A—Signaling by GPCR—PTCH1—skin cancer	0.000779	0.0014	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling by GPCR—SMO—skin cancer	0.000779	0.0014	CbGpPWpGaD
Dyphylline—PDE4C—Signaling Pathways—SMO—skin cancer	0.000768	0.00138	CbGpPWpGaD
Dyphylline—PDE4C—Signaling Pathways—PTCH1—skin cancer	0.000768	0.00138	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling by GPCR—PTGER4—skin cancer	0.000759	0.00136	CbGpPWpGaD
Dyphylline—PDE4C—Signaling Pathways—PTGER4—skin cancer	0.000748	0.00134	CbGpPWpGaD
Dyphylline—ADORA1—Circadian rythm related genes—IL6—skin cancer	0.000737	0.00132	CbGpPWpGaD
Dyphylline—Shock—Imiquimod—skin cancer	0.000736	0.0224	CcSEcCtD
Dyphylline—Tachycardia—Imiquimod—skin cancer	0.00073	0.0223	CcSEcCtD
Dyphylline—PDE7B—Signaling Pathways—TERT—skin cancer	0.000728	0.0013	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—GLI2—skin cancer	0.000714	0.00128	CbGpPWpGaD
Dyphylline—Hyperglycaemia—Temozolomide—skin cancer	0.000711	0.0217	CcSEcCtD
Dyphylline—PDE4D—Signaling Pathways—SHH—skin cancer	0.000706	0.00126	CbGpPWpGaD
Dyphylline—PDE4D—Signaling Pathways—RASA1—skin cancer	0.000701	0.00126	CbGpPWpGaD
Dyphylline—Flushing—Bleomycin—skin cancer	0.000694	0.0212	CcSEcCtD
Dyphylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—KRAS—skin cancer	0.000686	0.00123	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—MC1R—skin cancer	0.000681	0.00122	CbGpPWpGaD
Dyphylline—PDE7A—Signaling Pathways—TERT—skin cancer	0.000677	0.00121	CbGpPWpGaD
Dyphylline—Insomnia—Imiquimod—skin cancer	0.000676	0.0206	CcSEcCtD
Dyphylline—PDE4A—Signaling Pathways—SHH—skin cancer	0.000672	0.0012	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—GLI1—skin cancer	0.000672	0.0012	CbGpPWpGaD
Dyphylline—PDE4D—Signaling Pathways—SMO—skin cancer	0.000669	0.0012	CbGpPWpGaD
Dyphylline—PDE4D—Signaling Pathways—PTCH1—skin cancer	0.000669	0.0012	CbGpPWpGaD
Dyphylline—PDE4A—Signaling Pathways—RASA1—skin cancer	0.000667	0.0012	CbGpPWpGaD
Dyphylline—PDE4C—Signaling Pathways—FOXO4—skin cancer	0.000661	0.00118	CbGpPWpGaD
Dyphylline—PDE3A—Signaling Pathways—SHH—skin cancer	0.000653	0.00117	CbGpPWpGaD
Dyphylline—PDE4D—Signaling Pathways—PTGER4—skin cancer	0.000651	0.00117	CbGpPWpGaD
Dyphylline—PDE3A—Signaling Pathways—RASA1—skin cancer	0.000649	0.00116	CbGpPWpGaD
Dyphylline—Flushing—Dactinomycin—skin cancer	0.000647	0.0197	CcSEcCtD
Dyphylline—ADORA2A—Signaling Pathways—SUFU—skin cancer	0.000637	0.00114	CbGpPWpGaD
Dyphylline—PDE4A—Signaling Pathways—SMO—skin cancer	0.000637	0.00114	CbGpPWpGaD
Dyphylline—PDE4A—Signaling Pathways—PTCH1—skin cancer	0.000637	0.00114	CbGpPWpGaD
Dyphylline—ADORA1—Signaling Pathways—SHH—skin cancer	0.000629	0.00113	CbGpPWpGaD
Dyphylline—ADORA1—Signaling Pathways—RASA1—skin cancer	0.000625	0.00112	CbGpPWpGaD
Dyphylline—PDE4B—Signaling Pathways—SHH—skin cancer	0.000621	0.00111	CbGpPWpGaD
Dyphylline—ADORA2A—Circadian rythm related genes—TP53—skin cancer	0.000621	0.00111	CbGpPWpGaD
Dyphylline—PDE4A—Signaling Pathways—PTGER4—skin cancer	0.00062	0.00111	CbGpPWpGaD
Dyphylline—PDE3A—Signaling Pathways—SMO—skin cancer	0.000619	0.00111	CbGpPWpGaD
Dyphylline—PDE3A—Signaling Pathways—PTCH1—skin cancer	0.000619	0.00111	CbGpPWpGaD
Dyphylline—PDE4B—Signaling Pathways—RASA1—skin cancer	0.000618	0.00111	CbGpPWpGaD
Dyphylline—PDE7B—Signaling by GPCR—NRAS—skin cancer	0.000614	0.0011	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling by NGF—NRAS—skin cancer	0.000613	0.0011	CbGpPWpGaD
Dyphylline—PDE3A—Signaling Pathways—PTGER4—skin cancer	0.000603	0.00108	CbGpPWpGaD
Dyphylline—Diarrhoea—Vemurafenib—skin cancer	0.0006	0.0183	CcSEcCtD
Dyphylline—ADORA1—Signaling Pathways—SMO—skin cancer	0.000596	0.00107	CbGpPWpGaD
Dyphylline—ADORA1—Signaling Pathways—PTCH1—skin cancer	0.000596	0.00107	CbGpPWpGaD
Dyphylline—PDE4B—Signaling Pathways—PTCH1—skin cancer	0.000589	0.00106	CbGpPWpGaD
Dyphylline—PDE4B—Signaling Pathways—SMO—skin cancer	0.000589	0.00106	CbGpPWpGaD
Dyphylline—Flushing—Temozolomide—skin cancer	0.000585	0.0179	CcSEcCtD
Dyphylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—HRAS—skin cancer	0.000583	0.00104	CbGpPWpGaD
Dyphylline—ADORA1—Signaling Pathways—PTGER4—skin cancer	0.00058	0.00104	CbGpPWpGaD
Dyphylline—PDE7B—Signaling Pathways—BRAF—skin cancer	0.000577	0.00103	CbGpPWpGaD
Dyphylline—PDE4D—Signaling Pathways—FOXO4—skin cancer	0.000575	0.00103	CbGpPWpGaD
Dyphylline—PDE4B—Signaling Pathways—PTGER4—skin cancer	0.000573	0.00103	CbGpPWpGaD
Dyphylline—PDE7A—Signaling by GPCR—NRAS—skin cancer	0.000571	0.00102	CbGpPWpGaD
Dyphylline—ADORA2A—Circadian rythm related genes—IL6—skin cancer	0.000569	0.00102	CbGpPWpGaD
Dyphylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—IL6—skin cancer	0.000558	0.000999	CbGpPWpGaD
Dyphylline—Vomiting—Vemurafenib—skin cancer	0.000557	0.017	CcSEcCtD
Dyphylline—Abdominal pain upper—Docetaxel—skin cancer	0.000554	0.0169	CcSEcCtD
Dyphylline—Headache—Vemurafenib—skin cancer	0.000549	0.0168	CcSEcCtD
Dyphylline—PDE4A—Signaling Pathways—FOXO4—skin cancer	0.000547	0.000981	CbGpPWpGaD
Dyphylline—PDE7A—Signaling Pathways—BRAF—skin cancer	0.000536	0.000961	CbGpPWpGaD
Dyphylline—PDE3A—Signaling Pathways—FOXO4—skin cancer	0.000533	0.000954	CbGpPWpGaD
Dyphylline—PDE7B—Signaling by GPCR—KRAS—skin cancer	0.000528	0.000946	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling by NGF—KRAS—skin cancer	0.000527	0.000944	CbGpPWpGaD
Dyphylline—PDE3A—Hemostasis—NRAS—skin cancer	0.000522	0.000935	CbGpPWpGaD
Dyphylline—Nausea—Vemurafenib—skin cancer	0.000521	0.0159	CcSEcCtD
Dyphylline—ADORA1—Signaling Pathways—FOXO4—skin cancer	0.000513	0.000918	CbGpPWpGaD
Dyphylline—Diarrhoea—Imiquimod—skin cancer	0.000512	0.0156	CcSEcCtD
Dyphylline—PDE4B—Signaling Pathways—FOXO4—skin cancer	0.000507	0.000907	CbGpPWpGaD
Dyphylline—Agitation—Temozolomide—skin cancer	0.000504	0.0154	CcSEcCtD
Dyphylline—Hypotension—Bleomycin—skin cancer	0.000496	0.0151	CcSEcCtD
Dyphylline—PDE7A—Signaling by GPCR—KRAS—skin cancer	0.000491	0.000879	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—SHH—skin cancer	0.000486	0.00087	CbGpPWpGaD
Dyphylline—Palpitations—Temozolomide—skin cancer	0.000485	0.0148	CcSEcCtD
Dyphylline—ADORA2A—Signaling Pathways—RASA1—skin cancer	0.000483	0.000864	CbGpPWpGaD
Dyphylline—Convulsion—Temozolomide—skin cancer	0.000476	0.0145	CcSEcCtD
Dyphylline—Vomiting—Imiquimod—skin cancer	0.000475	0.0145	CcSEcCtD
Dyphylline—Headache—Imiquimod—skin cancer	0.000468	0.0143	CcSEcCtD
Dyphylline—ADORA2A—Signaling Pathways—PTCH1—skin cancer	0.00046	0.000824	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—SMO—skin cancer	0.00046	0.000824	CbGpPWpGaD
Dyphylline—PDE3A—Hemostasis—KRAS—skin cancer	0.000449	0.000805	CbGpPWpGaD
Dyphylline—PDE7B—Signaling by GPCR—HRAS—skin cancer	0.000449	0.000804	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling by NGF—HRAS—skin cancer	0.000448	0.000803	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—PTGER4—skin cancer	0.000448	0.000803	CbGpPWpGaD
Dyphylline—Nausea—Imiquimod—skin cancer	0.000444	0.0136	CcSEcCtD
Dyphylline—PDE4C—Signaling Pathways—TERT—skin cancer	0.000441	0.00079	CbGpPWpGaD
Dyphylline—Convulsion—Fluorouracil—skin cancer	0.000438	0.0134	CcSEcCtD
Dyphylline—PDE7B—Signaling by GPCR—IL6—skin cancer	0.00043	0.00077	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling by NGF—IL6—skin cancer	0.000429	0.000768	CbGpPWpGaD
Dyphylline—PDE7A—Signaling by GPCR—HRAS—skin cancer	0.000417	0.000748	CbGpPWpGaD
Dyphylline—Insomnia—Temozolomide—skin cancer	0.000405	0.0124	CcSEcCtD
Dyphylline—Tachycardia—Fluorouracil—skin cancer	0.000403	0.0123	CcSEcCtD
Dyphylline—PDE7A—Signaling by GPCR—IL6—skin cancer	0.000399	0.000716	CbGpPWpGaD
Dyphylline—PDE3A—Hemostasis—TP53—skin cancer	0.000399	0.000715	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—FOXO4—skin cancer	0.000396	0.000709	CbGpPWpGaD
Dyphylline—Flushing—Docetaxel—skin cancer	0.000389	0.0119	CcSEcCtD
Dyphylline—Hypotension—Fluorouracil—skin cancer	0.000386	0.0118	CcSEcCtD
Dyphylline—PDE4D—Signaling Pathways—TERT—skin cancer	0.000384	0.000688	CbGpPWpGaD
Dyphylline—PDE3A—Hemostasis—HRAS—skin cancer	0.000382	0.000684	CbGpPWpGaD
Dyphylline—Insomnia—Fluorouracil—skin cancer	0.000373	0.0114	CcSEcCtD
Dyphylline—PDE4C—Signaling by GPCR—NRAS—skin cancer	0.000372	0.000666	CbGpPWpGaD
Dyphylline—PDE4A—Signaling Pathways—TERT—skin cancer	0.000366	0.000655	CbGpPWpGaD
Dyphylline—PDE7B—Signaling Pathways—NRAS—skin cancer	0.000363	0.000649	CbGpPWpGaD
Dyphylline—PDE3A—Signaling Pathways—TERT—skin cancer	0.000356	0.000637	CbGpPWpGaD
Dyphylline—PDE4C—Signaling Pathways—BRAF—skin cancer	0.000349	0.000626	CbGpPWpGaD
Dyphylline—ADORA1—Signaling Pathways—TERT—skin cancer	0.000342	0.000613	CbGpPWpGaD
Dyphylline—Diarrhoea—Dactinomycin—skin cancer	0.000339	0.0103	CcSEcCtD
Dyphylline—PDE4B—Signaling Pathways—TERT—skin cancer	0.000338	0.000606	CbGpPWpGaD
Dyphylline—Vomiting—Bleomycin—skin cancer	0.000338	0.0103	CcSEcCtD
Dyphylline—PDE7A—Signaling Pathways—NRAS—skin cancer	0.000337	0.000604	CbGpPWpGaD
Dyphylline—PDE4D—Signaling by GPCR—NRAS—skin cancer	0.000324	0.00058	CbGpPWpGaD
Dyphylline—Palpitations—Docetaxel—skin cancer	0.000323	0.00984	CcSEcCtD
Dyphylline—PDE4C—Signaling by GPCR—KRAS—skin cancer	0.00032	0.000573	CbGpPWpGaD
Dyphylline—Convulsion—Docetaxel—skin cancer	0.000316	0.00965	CcSEcCtD
Dyphylline—Nausea—Bleomycin—skin cancer	0.000315	0.00963	CcSEcCtD
Dyphylline—Vomiting—Dactinomycin—skin cancer	0.000315	0.00961	CcSEcCtD
Dyphylline—PDE7B—Signaling Pathways—KRAS—skin cancer	0.000312	0.000559	CbGpPWpGaD
Dyphylline—PDE4A—Signaling by GPCR—NRAS—skin cancer	0.000308	0.000552	CbGpPWpGaD
Dyphylline—Diarrhoea—Temozolomide—skin cancer	0.000307	0.00935	CcSEcCtD
Dyphylline—PDE4D—Signaling Pathways—BRAF—skin cancer	0.000304	0.000545	CbGpPWpGaD
Dyphylline—PDE3A—Signaling by GPCR—NRAS—skin cancer	0.0003	0.000537	CbGpPWpGaD
Dyphylline—Nausea—Dactinomycin—skin cancer	0.000294	0.00898	CcSEcCtD
Dyphylline—Shock—Docetaxel—skin cancer	0.000293	0.00894	CcSEcCtD
Dyphylline—Tachycardia—Docetaxel—skin cancer	0.000291	0.00887	CcSEcCtD
Dyphylline—PDE7A—Signaling Pathways—KRAS—skin cancer	0.00029	0.00052	CbGpPWpGaD
Dyphylline—PDE4A—Signaling Pathways—BRAF—skin cancer	0.00029	0.000519	CbGpPWpGaD
Dyphylline—ADORA1—Signaling by GPCR—NRAS—skin cancer	0.000288	0.000517	CbGpPWpGaD
Dyphylline—PDE4B—Signaling by GPCR—NRAS—skin cancer	0.000285	0.000511	CbGpPWpGaD
Dyphylline—Vomiting—Temozolomide—skin cancer	0.000285	0.00869	CcSEcCtD
Dyphylline—Diarrhoea—Fluorouracil—skin cancer	0.000282	0.00862	CcSEcCtD
Dyphylline—PDE3A—Signaling Pathways—BRAF—skin cancer	0.000282	0.000505	CbGpPWpGaD
Dyphylline—Headache—Temozolomide—skin cancer	0.000281	0.00856	CcSEcCtD
Dyphylline—PDE4D—Signaling by GPCR—KRAS—skin cancer	0.000279	0.000499	CbGpPWpGaD
Dyphylline—Hypotension—Docetaxel—skin cancer	0.000278	0.0085	CcSEcCtD
Dyphylline—PDE7B—Signaling Pathways—TP53—skin cancer	0.000277	0.000497	CbGpPWpGaD
Dyphylline—PDE4C—Signaling by GPCR—HRAS—skin cancer	0.000272	0.000487	CbGpPWpGaD
Dyphylline—ADORA1—Signaling Pathways—BRAF—skin cancer	0.000271	0.000486	CbGpPWpGaD
Dyphylline—Insomnia—Docetaxel—skin cancer	0.000269	0.00822	CcSEcCtD
Dyphylline—PDE4B—Signaling Pathways—BRAF—skin cancer	0.000268	0.00048	CbGpPWpGaD
Dyphylline—Nausea—Temozolomide—skin cancer	0.000266	0.00812	CcSEcCtD
Dyphylline—PDE7B—Signaling Pathways—HRAS—skin cancer	0.000265	0.000475	CbGpPWpGaD
Dyphylline—PDE4A—Signaling by GPCR—KRAS—skin cancer	0.000265	0.000475	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—TERT—skin cancer	0.000264	0.000474	CbGpPWpGaD
Dyphylline—Vomiting—Fluorouracil—skin cancer	0.000262	0.00801	CcSEcCtD
Dyphylline—PDE4C—Signaling by GPCR—IL6—skin cancer	0.00026	0.000466	CbGpPWpGaD
Dyphylline—Headache—Fluorouracil—skin cancer	0.000259	0.00789	CcSEcCtD
Dyphylline—PDE3A—Signaling by GPCR—KRAS—skin cancer	0.000258	0.000462	CbGpPWpGaD
Dyphylline—PDE7A—Signaling Pathways—TP53—skin cancer	0.000258	0.000462	CbGpPWpGaD
Dyphylline—PDE7B—Signaling Pathways—IL6—skin cancer	0.000254	0.000455	CbGpPWpGaD
Dyphylline—ADORA1—Signaling by GPCR—KRAS—skin cancer	0.000248	0.000445	CbGpPWpGaD
Dyphylline—PDE7A—Signaling Pathways—HRAS—skin cancer	0.000247	0.000442	CbGpPWpGaD
Dyphylline—PDE4B—Signaling by GPCR—KRAS—skin cancer	0.000245	0.000439	CbGpPWpGaD
Dyphylline—Nausea—Fluorouracil—skin cancer	0.000245	0.00748	CcSEcCtD
Dyphylline—PDE4D—Signaling by GPCR—HRAS—skin cancer	0.000237	0.000424	CbGpPWpGaD
Dyphylline—PDE7A—Signaling Pathways—IL6—skin cancer	0.000236	0.000423	CbGpPWpGaD
Dyphylline—PDE4D—Signaling by GPCR—IL6—skin cancer	0.000227	0.000406	CbGpPWpGaD
Dyphylline—PDE4A—Signaling by GPCR—HRAS—skin cancer	0.000225	0.000404	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling by GPCR—NRAS—skin cancer	0.000223	0.000399	CbGpPWpGaD
Dyphylline—PDE4C—Signaling Pathways—NRAS—skin cancer	0.00022	0.000393	CbGpPWpGaD
Dyphylline—PDE3A—Signaling by GPCR—HRAS—skin cancer	0.000219	0.000393	CbGpPWpGaD
Dyphylline—PDE4A—Signaling by GPCR—IL6—skin cancer	0.000216	0.000386	CbGpPWpGaD
Dyphylline—ADORA1—Signaling by GPCR—HRAS—skin cancer	0.000211	0.000378	CbGpPWpGaD
Dyphylline—PDE3A—Signaling by GPCR—IL6—skin cancer	0.00021	0.000376	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—BRAF—skin cancer	0.000209	0.000375	CbGpPWpGaD
Dyphylline—PDE4B—Signaling by GPCR—HRAS—skin cancer	0.000209	0.000374	CbGpPWpGaD
Dyphylline—Diarrhoea—Docetaxel—skin cancer	0.000204	0.00622	CcSEcCtD
Dyphylline—ADORA1—Signaling by GPCR—IL6—skin cancer	0.000202	0.000362	CbGpPWpGaD
Dyphylline—PDE4B—Signaling by GPCR—IL6—skin cancer	0.0002	0.000358	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling by GPCR—KRAS—skin cancer	0.000192	0.000343	CbGpPWpGaD
Dyphylline—PDE4D—Signaling Pathways—NRAS—skin cancer	0.000191	0.000342	CbGpPWpGaD
Dyphylline—Vomiting—Docetaxel—skin cancer	0.000189	0.00578	CcSEcCtD
Dyphylline—PDE4C—Signaling Pathways—KRAS—skin cancer	0.000189	0.000339	CbGpPWpGaD
Dyphylline—Headache—Docetaxel—skin cancer	0.000187	0.0057	CcSEcCtD
Dyphylline—PDE4A—Signaling Pathways—NRAS—skin cancer	0.000182	0.000326	CbGpPWpGaD
Dyphylline—PDE3A—Signaling Pathways—NRAS—skin cancer	0.000177	0.000317	CbGpPWpGaD
Dyphylline—Nausea—Docetaxel—skin cancer	0.000177	0.0054	CcSEcCtD
Dyphylline—ADORA1—Signaling Pathways—NRAS—skin cancer	0.00017	0.000305	CbGpPWpGaD
Dyphylline—PDE4B—Signaling Pathways—NRAS—skin cancer	0.000168	0.000302	CbGpPWpGaD
Dyphylline—PDE4C—Signaling Pathways—TP53—skin cancer	0.000168	0.000301	CbGpPWpGaD
Dyphylline—PDE4D—Signaling Pathways—KRAS—skin cancer	0.000165	0.000295	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling by GPCR—HRAS—skin cancer	0.000163	0.000292	CbGpPWpGaD
Dyphylline—PDE4C—Signaling Pathways—HRAS—skin cancer	0.000161	0.000288	CbGpPWpGaD
Dyphylline—PDE4A—Signaling Pathways—KRAS—skin cancer	0.000157	0.000281	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling by GPCR—IL6—skin cancer	0.000156	0.000279	CbGpPWpGaD
Dyphylline—PDE4C—Signaling Pathways—IL6—skin cancer	0.000154	0.000275	CbGpPWpGaD
Dyphylline—PDE3A—Signaling Pathways—KRAS—skin cancer	0.000152	0.000273	CbGpPWpGaD
Dyphylline—ADORA1—Signaling Pathways—KRAS—skin cancer	0.000147	0.000263	CbGpPWpGaD
Dyphylline—PDE4D—Signaling Pathways—TP53—skin cancer	0.000146	0.000262	CbGpPWpGaD
Dyphylline—PDE4B—Signaling Pathways—KRAS—skin cancer	0.000145	0.00026	CbGpPWpGaD
Dyphylline—PDE4D—Signaling Pathways—HRAS—skin cancer	0.00014	0.000251	CbGpPWpGaD
Dyphylline—PDE4A—Signaling Pathways—TP53—skin cancer	0.000139	0.000249	CbGpPWpGaD
Dyphylline—PDE3A—Signaling Pathways—TP53—skin cancer	0.000135	0.000243	CbGpPWpGaD
Dyphylline—PDE4D—Signaling Pathways—IL6—skin cancer	0.000134	0.00024	CbGpPWpGaD
Dyphylline—PDE4A—Signaling Pathways—HRAS—skin cancer	0.000133	0.000238	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—NRAS—skin cancer	0.000132	0.000236	CbGpPWpGaD
Dyphylline—ADORA1—Signaling Pathways—TP53—skin cancer	0.00013	0.000233	CbGpPWpGaD
Dyphylline—PDE3A—Signaling Pathways—HRAS—skin cancer	0.00013	0.000232	CbGpPWpGaD
Dyphylline—PDE4B—Signaling Pathways—TP53—skin cancer	0.000129	0.000231	CbGpPWpGaD
Dyphylline—PDE4A—Signaling Pathways—IL6—skin cancer	0.000127	0.000228	CbGpPWpGaD
Dyphylline—ADORA1—Signaling Pathways—HRAS—skin cancer	0.000125	0.000223	CbGpPWpGaD
Dyphylline—PDE3A—Signaling Pathways—IL6—skin cancer	0.000124	0.000222	CbGpPWpGaD
Dyphylline—PDE4B—Signaling Pathways—HRAS—skin cancer	0.000123	0.000221	CbGpPWpGaD
Dyphylline—ADORA1—Signaling Pathways—IL6—skin cancer	0.000119	0.000214	CbGpPWpGaD
Dyphylline—PDE4B—Signaling Pathways—IL6—skin cancer	0.000118	0.000211	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—KRAS—skin cancer	0.000113	0.000203	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—TP53—skin cancer	0.000101	0.00018	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—HRAS—skin cancer	9.63e-05	0.000172	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—IL6—skin cancer	9.21e-05	0.000165	CbGpPWpGaD
